Skip to main content

Share story

Products

US confirms an orbital space weapon deployment

A view of Earth taken by NASA astronaut and Artemis II commander Reid Wiseman from the Orion spacecraft's window after completing the translunar injection burn on April 2, 2026. Image: Primary
The United States has confirmed that it deployed a weapon in Earth's orbit, according to comments by Air Force Secretary Troy Meink reported by the BBC. Meink said the on-orbit weapon was needed to safeguard U.S. forces against hostile action, but did not describe its capability or say when it was deployed. A Space Force spokesperson said space-control capabilities can use kinetic and non-kinetic means to disrupt, degrade or destroy adversary capabilities when directed by combatant commands. China warned against an arms race in space.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from bbc.com and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
AI Infrastructure
AI Infrastructure

Five technology giants commit more than $3T to future spending

Alphabet, Meta, Microsoft, Amazon and Oracle have committed more than $3T to future spending on data centres, leases, equipment and energy, The Next Web reported, citing Bloomberg. Alphabet accounts for more than $1T and Meta for more than $800B.

Products AI
Products AI

Salesforce's Rune acquisition agreement reportedly worth $375 million

Salesforce's agreement to acquire military logistics software developer Rune Technologies is worth $375 million in cash and stock, Resilience Media reported. Rune builds AI software that helps the US military predict supply needs and manage logistics in the field.

AI Science
AI Science

Insilico says AI-discovered Rentosertib has entered Phase III trials

Insilico Medicine says Rentosertib, its generative AI-discovered drug candidate also known as ISM001-055, has entered Phase III clinical trials for idiopathic pulmonary fibrosis. The company described the clinical advance in an announcement carried by News-Medical.Net.